| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00016 | 1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 9.1e-05 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.00011 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 4.2e-05 | 1 |